Anxiety
FDA probes herbal supplement
Published in Medical Letter on the CDC and FDA, March 17th, 2002
European health officials report 25 similar cases of liver toxicity, and some countries are barring kava sales. Now the U.S. Food and Drug Administration (FDA) is investigating whether the herbal sedative - promoted to relieve anxiety, stress and insomnia - poses a danger.
Under review are 38 Americans, including the transplant recipient, with medical problems possibly associated with kava use. FDA scientists cannot yet say if the blockbuster seller is to blame.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Developing Nations
HIV/AIDS impact on education intensifies economic downfall - Diagnostics
Study shows promising use of proteomics and bioinformatics in ovarian cancer detection - Diabetes Mellitus
Record analysis shows slight connection between inflammation and disease - Phenylketonuria
Women with PKU should follow special diet before and during pregnancy - Adverse Drug Events
FDA recalls two herbal supplements - Anthrax
New vaccines will take awhile - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
